Unlocking the potential of the human genome with RNA interference (original) (raw)

• Fire, A., Albertson, D., Harrison, S. W. & Moerman, D. G. Production of antisense RNA leads to effective and specific inhibition of gene expression in C. elegans muscle. Development 113, 503–514 (1991).
  CAS PubMed Google Scholar
• Guo, S. & Kemphues, K. J. par-1, a gene required for establishing polarity in C. elegans embryos, encodes a putative Ser/Thr kinase that is asymmetrically distributed. Cell 81, 611–620 (1995).
  CAS PubMed Google Scholar
• Fire, A. et al. Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans. Nature 391, 806–811 (1998).
  ADS CAS PubMed Google Scholar
• Hannon, G. J. RNA interference. Nature 418, 244–251 (2002).
  Article ADS CAS PubMed Google Scholar
• Williams, B. R. Role of the double-stranded RNA-activated protein kinase (PKR) in cell regulation. Biochem. Soc. Trans. 25, 509–513 (1997).
  CAS PubMed Google Scholar
• Bernstein, E., Caudy, A. A., Hammond, S. M. & Hannon, G. J. Role for a bidentate ribonuclease in the initiation step of RNA interference. Nature 409, 363–366 (2001).
  ADS CAS PubMed Google Scholar
• Hammond, S. M., Boettcher, S., Caudy, A. A., Kobayashi, R. & Hannon, G. J. Argonaute2, a link between genetic and biochemical analyses of RNAi. Science 293, 1146–1150 (2001).
  CAS PubMed Google Scholar
• Elbashir, S. M. et al. Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature 411, 494–498 (2001).
  ADS CAS PubMed Google Scholar
• Hutvágner, G. et al. A cellular function for the RNA-interference enzyme Dicer in the maturation of the let-7 small temporal RNA. Science 293, 834–838 (2001).
  PubMed Google Scholar
• Grishok, A. et al. Genes and mechanisms related to RNA interference regulate expression of the small temporal RNAs that control C. elegans developmental timing. Cell 106, 23–34 (2001).
  CAS PubMed Google Scholar
• Ketting, R. F. et al. Dicer functions in RNA interference and in synthesis of small RNA involved in developmental timing in C. elegans. Genes Dev. 15, 2654–2659 (2001).
  CAS PubMed PubMed Central Google Scholar
• Paddison, P. J., Caudy, A. A., Sachidanandam, R. & Hannon, G. J. Short hairpin activated gene silencing in mammalian cells. Methods Mol. Biol. 265, 85–100 (2004).
  CAS PubMed Google Scholar
• Khvorova, A., Reynolds, A. & Jayasena, S. D. Functional siRNAs and miRNAs exhibit strand bias. Cell 115, 209–216 (2003).
  CAS PubMed Google Scholar
• Schwarz, D. S. et al. Asymmetry in the assembly of the RNAi enzyme complex. Cell 115, 199–208 (2003).
  CAS PubMed Google Scholar
• Reynolds, A. et al. Rational siRNA design for RNA interference. Nature Biotechnol. 22, 326–330 (2004).
  CAS Google Scholar
• Silva, J. M., Sachidanandam, R. & Hannon, G. J. Free energy lights the path toward more effective RNAi. Nature Genet. 35, 303–305 (2003).
  CAS PubMed Google Scholar
• Aza-Blanc, P. et al. Identification of modulators of TRAIL-induced apoptosis via RNAi-based phenotypic screening. Mol. Cell 12, 627–637 (2003).
  CAS PubMed Google Scholar
• Pebernard, S. & Iggo, R. D. Determinants of interferon-stimulated gene induction by RNAi vectors. Differentiation 72, 103–111 (2004).
  CAS PubMed Google Scholar
• Persengiev, S. P., Zhu, X. & Green, M. R. Nonspecific, concentration-dependent stimulation and repression of mammalian gene expression by small interfering RNAs (siRNAs). RNA 10, 12–18 (2004).
  CAS PubMed PubMed Central Google Scholar
• Sledz, C. A., Holko, M., de Veer, M. J., Silverman, R. H. & Williams, B. R. Activation of the interferon system by short-interfering RNAs. Nature Cell Biol. 5, 834–839 (2003).
  CAS PubMed Google Scholar
• Kim, D. H. et al. Interferon induction by siRNAs and ssRNAs synthesized by phage polymerase. Nature Biotechnol. 22, 321–325 (2004).
  CAS Google Scholar
• Jackson, A. L. et al. Expression profiling reveals off-target gene regulation by RNAi. Nature Biotechnol. 21, 635–637 (2003).
  CAS Google Scholar
• Doench, J. G. & Sharp, P. A. Specificity of microRNA target selection in translational repression. Genes Dev. 18, 504–511 (2004).
  CAS PubMed PubMed Central Google Scholar
• Lai, E. C., Tomancak, P., Williams, R. W. & Rubin, G. M. Computational identification of Drosophila microRNA genes. Genome Biol. 4, R42 (2003).
  PubMed PubMed Central Google Scholar
• Lewis, B. P., Shih, I. H., Jones-Rhoades, M. W., Bartel, D. P. & Burge, C. B. Prediction of mammalian microRNA targets. Cell 115, 787–798 (2003).
  CAS PubMed Google Scholar
• Enright, A. J. et al. MicroRNA targets in Drosophila. Genome Biol. 5, R1 (2003).
  PubMed PubMed Central Google Scholar
• Scacheri, P. C. et al. Short interfering RNAs can induce unexpected and divergent changes in the levels of untargeted proteins in mammalian cells. Proc. Natl Acad. Sci. USA 101, 1892–1897 (2004).
  ADS CAS PubMed PubMed Central Google Scholar
• McCaffrey, A. P. et al. RNA interference in adult mice. Nature 418, 38–39 (2002).
  ADS CAS PubMed Google Scholar
• Matsuda, T. & Cepko, C. L. Electroporation and RNA interference in the rodent retina in vivo and in vitro. Proc. Natl Acad. Sci. USA 101, 16–22 (2004).
  ADS CAS PubMed Google Scholar
• Layzer, J. M. et al. In vivo activity of nuclease-resistant siRNAs. RNA 10, 766–771 (2004).
  CAS PubMed PubMed Central Google Scholar
• Lewis, D. L., Hagstrom, J. E., Loomis, A. G., Wolff, J. A. & Herweijer, H. Efficient delivery of siRNA for inhibition of gene expression in postnatal mice. Nature Genet. 32, 107–108 (2002).
  CAS PubMed Google Scholar
• Sorensen, D. R., Leirdal, M. & Sioud, M. Gene silencing by systemic delivery of synthetic siRNAs in adult mice. J. Mol. Biol. 327, 761–766 (2003).
  CAS PubMed Google Scholar
• Brummelkamp, T. R., Bernards, R. & Agami, R. Stable suppression of tumorigenicity by virus-mediated RNA interference. Cancer Cell 2, 243–247 (2002).
  CAS PubMed Google Scholar
• Rubinson, D. A. et al. A lentivirus-based system to functionally silence genes in primary mammalian cells, stem cells and transgenic mice by RNA interference. Nature Genet. 33, 401–406 (2003).
  CAS PubMed Google Scholar
• Hemann, M. T. et al. An epi-allelic series of p53 hypomorphs created by stable RNAi produces distinct tumor phenotypes in vivo. Nature Genet. 33, 396–400 (2003).
  CAS PubMed Google Scholar
• Carmell, M. A., Zhang, L., Conklin, D. S., Hannon, G. J. & Rosenquist, T. A. Germline transmission of RNAi in mice. Nature Struct. Biol. 10, 91–92 (2003).
  CAS PubMed Google Scholar
• Tiscornia, G., Singer, O., Ikawa, M. & Verma, I. M. A general method for gene knockdown in mice by using lentiviral vectors expressing small interfering RNA. Proc. Natl Acad. Sci. USA 100, 1844–1848 (2003).
  ADS CAS PubMed PubMed Central Google Scholar
• Hasuwa, H., Kaseda, K., Einarsdottir, T. & Okabe, M. Small interfering RNA and gene silencing in transgenic mice and rats. FEBS Lett. 532, 227–230 (2002).
  CAS PubMed Google Scholar
• Kunath, T. et al. Transgenic RNA interference in ES cell-derived embryos recapitulates a genetic null phenotype. Nature Biotechnol. 21, 559–561 (2003).
  CAS Google Scholar
• Hsieh, A. C. et al. A library of siRNA duplexes targeting the phosphoinositide 3-kinase pathway: determinants of gene silencing for use in cell-based screens. Nucleic Acids Res. 32, 893–901 (2004).
  CAS PubMed PubMed Central Google Scholar
• Brummelkamp, T. R., Nijman, S. M., Dirac, A. M. & Bernards, R. Loss of the cylindromatosis tumour suppressor inhibits apoptosis by activating NF-κB. Nature 424, 797–801 (2003).
  ADS CAS PubMed Google Scholar
• Berns, K. et al. A large-scale RNAi screen in human cells identifies new components of the p53 pathway. Nature 428, 431–437 (2004).
  ADS CAS PubMed Google Scholar
• Paddison, P. J. et al. A resource for large-scale RNA-interference-based screens in mammals. Nature 428, 427–431 (2004).
  ADS CAS PubMed Google Scholar
• Zheng, L. et al. An approach to genomewide screens of expressed small interfering RNAs in mammalian cells. Proc. Natl Acad. Sci. USA 101, 135–140 (2004).
  ADS CAS PubMed Google Scholar
• Luo, B., Heard, A. D. & Lodish, H. F. Small interfering RNA production by enzymatic engineering of DNA (SPEED). Proc. Natl Acad. Sci. USA 101, 5494–5499 (2004).
  ADS CAS PubMed PubMed Central Google Scholar
• Shirane, D. et al. Enzymatic production of RNAi libraries from cDNAs. Nature Genet. 36, 190–196 (2004).
  CAS PubMed Google Scholar
• Sen, G., Wehrman, T. S., Myers, J. W. & Blau, H. M. Restriction enzyme-generated siRNA (REGS) vectors and libraries. Nature Genet. 36, 183–189 (2004).
  CAS PubMed Google Scholar
• Silva, J. M., Mizuno, H., Brady, A., Lucito, R. & Hannon, G. J. RNA interference microarrays: high-throughput loss-of-function genetics in mammalian cells. Proc. Natl Acad. Sci. USA 101, 6548–6552 (2004).
  ADS CAS PubMed PubMed Central Google Scholar
• Ziauddin, J. & Sabatini, D. M. Microarrays of cells expressing defined cDNAs. Nature 411, 107–110 (2001).
  ADS CAS PubMed Google Scholar
• Jacque, J. M., Triques, K. & Stevenson, M. Modulation of HIV-1 replication by RNA interference. Nature 418, 435–438 (2002).
  ADS CAS PubMed Google Scholar
• Lee, N. S. et al. Expression of small interfering RNAs targeted against HIV-1 rev transcripts in human cells. Nature Biotechnol. 20, 500–505 (2002).
  CAS Google Scholar
• Coburn, G. A. & Cullen, B. R. Potent and specific inhibition of human immunodeficiency virus type-1 replication by RNA interference. J. Virol. 76, 9225–9231 (2002).
  CAS PubMed PubMed Central Google Scholar
• Surabhi, R. M. & Gaynor, R. B. RNA interference directed against viral and cellular targets inhibits human immunodeficiency virus type-1 replication. J. Virol. 76, 12963–12973 (2002).
  CAS PubMed PubMed Central Google Scholar
• Novina, C. D. et al. siRNA-directed inhibition of HIV-1 infection. Nature Med. 8, 681–686 (2002).
  CAS PubMed Google Scholar
• Park, W. S. et al. Prevention of HIV-1 infection in human peripheral blood mononuclear cells by specific RNA interference. Nucleic Acids Res. 30, 4830–4835 (2002).
  CAS PubMed PubMed Central Google Scholar
• Boden, D., Pusch, O., Lee, F., Tucker, L. & Ramratnam, B. Human immunodeficiency virus type-1 escape from RNA interference. J. Virol. 77, 11531–11535 (2003).
  CAS PubMed PubMed Central Google Scholar
• Martinez, M. A. et al. Suppression of chemokine receptor expression by RNA interference allows for inhibition of HIV-1 replication. AIDS 16, 2385–2390 (2002).
  CAS PubMed Google Scholar
• Capodici, J., Kariko, K. & Weissman, D. Inhibition of HIV-1 infection by small interfering RNA-mediated RNA interference. J. Immunol. 169, 5196–5201 (2002).
  PubMed Google Scholar
• Banerjea, A. et al. Inhibition of HIV-1 by lentiviral vector-transduced siRNAs in T lymphocytes differentiated in SCID-hu mice and CD34+ progenitor cell-derived macrophages. Mol. Ther. 8, 62–71 (2003).
  CAS PubMed Google Scholar
• Li, M. J. et al. Inhibition of HIV-1 infection by lentiviral vectors expressing Pol III-promoted anti-HIV RNAs. Mol. Ther. 8, 196–206 (2003).
  CAS PubMed Google Scholar
• Eugen-Olsen, J. et al. Heterozygosity for a deletion in the CKR-5 gene leads to prolonged AIDS-free survival and slower CD4 T-cell decline in a cohort of HIV-seropositive individuals. AIDS 11, 305–310 (1997).
  CAS PubMed Google Scholar
• Samson, M. et al. Resistance to HIV-1 infection in caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor gene. Nature 382, 722–725 (1996).
  ADS CAS PubMed Google Scholar
• Qin, X. F., An, D. S., Chen, I. S. & Baltimore, D. Inhibiting HIV-1 infection in human T cells by lentiviral-mediated delivery of small interfering RNA against CCR5. Proc. Natl Acad. Sci. USA 100, 183–188 (2003).
  ADS CAS PubMed Google Scholar
• Dell'Agnola, C. et al. In vitro and in vivo hematopoietic potential of human stem cells residing in muscle tissue. Exp. Hematol. 30, 905–914 (2002).
  CAS PubMed Google Scholar
• Dropulic, B. Lentivirus in the clinic. Mol. Ther. 4, 511–512 (2001).
  CAS PubMed Google Scholar
• Davis, B. M., Humeau, L. & Dropulic, B. In vivo selection for human and murine hematopoietic cells transduced with a therapeutic MGMT lentiviral vector that inhibits HIV replication. Mol. Ther. 9, 160–172 (2004).
  CAS PubMed Google Scholar
• Amado, R. G. et al. Anti-human immunodeficiency virus hematopoietic progenitor cell-delivered ribozyme in a phase I study: myeloid and lymphoid reconstitution in human immunodeficiency virus type-1-infected patients. Hum. Gene Ther. 15, 251–262 (2004).
  CAS PubMed Google Scholar
• Michienzi, A. et al. RNA-mediated inhibition of HIV in a gene therapy setting. Ann. NY Acad. Sci. 1002, 63–71 (2003).
  ADS CAS PubMed Google Scholar
• McCaffrey, A. P. et al. Inhibition of hepatitis B virus in mice by RNA interference. Nature Biotechnol. 6, 639–644 (2003).
  Google Scholar
• Blight, K. J., Kolykhalov, A. A. & Rice, C. M. Efficient initiation of HCV RNA replication in cell culture. Science 290, 1972–1974 (2000).
  ADS CAS PubMed Google Scholar
• Lohmann, V. et al. Replication of subgenomic hepatitis C virus RNAs in a hepatoma cell line. Science 285, 110–113 (1999).
  CAS PubMed Google Scholar
• Ikeda, M., Yi, M., Li, K. & Lemon, S. M. Selectable subgenomic and genome-length dicistronic RNAs derived from an infectious molecular clone of the HCV-N strain of hepatitis C virus replicate efficiently in cultured Huh7 cells. J. Virol. 76, 2997–3006 (2002).
  CAS PubMed PubMed Central Google Scholar
• Pietschmann, T., Lohmann, V., Rutter, G., Kurpanek, K. & Bartenschlager, R. Characterization of cell lines carrying self-replicating hepatitis C virus RNAs. J. Virol. 75, 1252–1264 (2001).
  CAS PubMed PubMed Central Google Scholar
• Randall, G., Grakoui, A. & Rice, C. M. Clearance of replicating hepatitis C virus replicon RNAs in cell culture by small interfering RNAs. Proc. Natl Acad. Sci. USA 100, 235–240 (2003).
  ADS CAS PubMed Google Scholar
• Wilson, J. A. et al. RNA interference blocks gene expression and RNA synthesis from hepatitis C replicons propagated in human liver cells. Proc. Natl Acad. Sci. USA 100, 2783–2788 (2003).
  ADS CAS PubMed PubMed Central Google Scholar
• Kapadia, S. B., Brideau-Andersen, A. & Chisari, F. V. Interference of hepatitis C virus RNA replication by short interfering RNAs. Proc. Natl Acad. Sci. USA 100, 2014–2018 (2003).
  ADS CAS PubMed PubMed Central Google Scholar
• Song, E. et al. RNA interference targeting Fas protects mice from fulminant hepatitis. Nature Med. 9, 347–351 (2003).
  CAS PubMed Google Scholar
• Eastman, S. J. et al. Development of catheter-based procedures for transducing the isolated rabbit liver with plasmid DNA. Hum. Gene Ther. 13, 2065–2077 (2002).
  CAS PubMed Google Scholar
• Kittler, R. & Buchholz, F. RNA interference: gene silencing in the fast lane. Semin. Cancer Biol. 13, 259–265 (2003).
  CAS PubMed Google Scholar
• Wall, N. R. & Shi, Y. Small RNA: can RNA interference be exploited for therapy? Lancet 362, 1401–1403 (2003).
  CAS PubMed Google Scholar
• Lu, P. Y., Xie, F. Y. & Woodle, M. C. siRNA-mediated antitumorigenesis for drug target validation and therapeutics. Curr. Opin. Mol. Ther. 5, 225–234 (2003).
  CAS PubMed Google Scholar
• Buchele, T. Proapoptotic therapy with oblimersen (bcl-2 antisense oligonucleotide)—review of preclinical and clinical results. Onkologie 26, (Suppl. 7), 60–69 (2003).
  PubMed Google Scholar
• Chiu, Y. L. & Rana, T. M. siRNA function in RNAi: a chemical modification analysis. RNA 9, 1034–1048 (2003).
  CAS PubMed PubMed Central Google Scholar
• Czauderna, F. et al. Structural variations and stabilising modifications of synthetic siRNAs in mammalian cells. Nucleic Acids Res. 31, 2705–2716 (2003).
  CAS PubMed PubMed Central Google Scholar
• Wang, L., Prakash, R. K., Stein, C. A., Koehn, R. K. & Ruffner, D. E. Progress in the delivery of therapeutic oligonucleotides: organ/cellular distribution and targeted delivery of oligonucleotides in vivo. Antisense Nucleic Acid Drug Dev. 13, 169–189 (2003).
  CAS PubMed Google Scholar
• Holtz, M. S. & Bhatia, R. Effect of imatinib mesylate on chronic myelogenous leukemia hematopoietic progenitor cells. Leuk. Lymphoma 45, 237–245 (2004).
  CAS PubMed Google Scholar
• Tauchi, T. & Ohyashiki, K. Molecular mechanisms of resistance of leukemia to imatinib mesylate. Leuk. Res. 28 (Suppl. 1), 39–45 (2004).
  Google Scholar
• Cowan-Jacob, S. W. et al. Imatinib (STI571) resistance in chronic myelogenous leukemia: molecular basis of the underlying mechanisms and potential strategies for treatment. Mini Rev. Med. Chem. 4, 285–299 (2004).
  CAS PubMed Google Scholar
• Marcucci, G., Perrotti, D. & Caligiuri, M. A. Understanding the molecular basis of imatinib mesylate therapy in chronic myelogenous leukemia and the related mechanisms of resistance. Commentary. Clin. Cancer Res., 9: 1333–1337, 2003. Clin. Cancer Res. 9, 1248–1252 (2003).
  Google Scholar
• Li, M. J., McMahon, R., Snyder, D. S., Yee, J. K. & Rossi, J. J. Specific killing of Ph+ chronic myeloid leukemia cells by a lentiviral vector-delivered anti-bcr/abl small hairpin RNA. Oligonucleotides 13, 401–409 (2003).
  CAS PubMed Google Scholar
• Wohlbold, L. et al. Inhibition of bcr-abl gene expression by small interfering RNA sensitizes for imatinib mesylate (STI571). Blood 102, 2236–2239 (2003).
  CAS PubMed Google Scholar
• Scherr, M. et al. Specific inhibition of bcr-abl gene expression by small interfering RNA. Blood 101, 1566–1569 (2003).
  CAS PubMed Google Scholar
• Miller, V. M., Gouvion, C. M., Davidson, B. L. & Paulson, H. L. Targeting Alzheimer's disease genes with RNA interference: an efficient strategy for silencing mutant alleles. Nucleic Acids Res. 32, 661–668 (2004).
  CAS PubMed PubMed Central Google Scholar
• Miller, V. M. et al. Allele-specific silencing of dominant disease genes. Proc. Natl Acad. Sci. USA 100, 7195–7200 (2003).
  ADS CAS PubMed PubMed Central Google Scholar
• Ding, H. et al. Selective silencing by RNAi of a dominant allele that causes amyotrophic lateral sclerosis. Aging Cell 2, 209–217 (2003).
  CAS PubMed Google Scholar
• Davidson, B. L. & Paulson, H. L. Molecular medicine for the brain: silencing of disease genes with RNA interference. Lancet Neurol. 3, 145–149 (2004).
  CAS PubMed Google Scholar
• Pasquinelli, A. E. MicroRNAs: deviants no longer. Trends Genet. 18, 171–173 (2002).
  CAS PubMed Google Scholar
• Moss, E. G. MicroRNAs: hidden in the genome. Curr. Biol. 12, R138–R140 (2002).
  CAS PubMed Google Scholar
• Hutvágner, G., Simard, M. J., Mello, C. C. & Zamore, P. D. Sequence-specific inhibition of small RNA function. PLoS Biol. 2, E98 (2004).
  PubMed PubMed Central Google Scholar
• Saxena, S., Jonsson, Z. O. & Dutta, A. Small RNAs with imperfect match to endogenous mRNA repress translation. Implications for off-target activity of small inhibitory RNA in mammalian cells. J. Biol. Chem. 278, 44312–44319 (2003).
  CAS PubMed Google Scholar